LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAF5. A total of 23 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $18,815 | +94.0% | 19,000 | +90.0% | 0.00% | – |
| Q4 2022 | $9,698 | -99.1% | 10,000 | -99.1% | 0.00% | – |
| Q3 2022 | $1,049,000 | -75.7% | 1,084,000 | -76.0% | 0.00% | -100.0% |
| Q2 2022 | $4,321,000 | -8.0% | 4,513,000 | -6.6% | 0.00% | 0.0% |
| Q1 2022 | $4,697,000 | -21.0% | 4,834,000 | -19.1% | 0.00% | 0.0% |
| Q4 2021 | $5,946,000 | -17.0% | 5,972,000 | -16.5% | 0.00% | 0.0% |
| Q3 2021 | $7,166,000 | 0.0% | 7,154,000 | -1.6% | 0.00% | 0.0% |
| Q2 2021 | $7,166,000 | -4.0% | 7,268,000 | +1.7% | 0.00% | 0.0% |
| Q1 2021 | $7,466,000 | -17.8% | 7,148,000 | -26.0% | 0.00% | 0.0% |
| Q4 2020 | $9,080,000 | +105.6% | 9,662,000 | +96.8% | 0.00% | 0.0% |
| Q3 2020 | $4,416,000 | -41.3% | 4,909,000 | -42.1% | 0.00% | -50.0% |
| Q2 2020 | $7,520,000 | +280.8% | 8,485,000 | +252.2% | 0.00% | +100.0% |
| Q1 2020 | $1,975,000 | -5.1% | 2,409,000 | 0.0% | 0.00% | – |
| Q4 2019 | $2,082,000 | -59.5% | 2,409,000 | -60.9% | 0.00% | -100.0% |
| Q3 2019 | $5,142,000 | +1.9% | 6,159,000 | +5.3% | 0.00% | 0.0% |
| Q2 2019 | $5,045,000 | – | 5,849,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| STEELHEAD PARTNERS LLC | 64,118,000 | $55,709,000 | 4.91% |
| SYMPHONY ASSET MANAGEMENT LLC | 9,000,000 | $7,790,000 | 1.72% |
| CANYON CAPITAL ADVISORS LLC | 65,000,000 | $56,160,000 | 1.31% |
| CAMDEN ASSET MANAGEMENT L P /CA | 44,450,000 | $38,362,000 | 1.24% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 60,954,000 | $52,832,000 | 1.02% |
| Context Capital Management, LLC | 2,350,000 | $2,028,000 | 1.02% |
| SHENKMAN CAPITAL MANAGEMENT INC | 4,160,000 | $3,622,000 | 0.47% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 22,500,000 | $19,418,000 | 0.44% |
| OAKTREE CAPITAL MANAGEMENT LP | 23,903,000 | $20,688,000 | 0.39% |
| WOLVERINE ASSET MANAGEMENT LLC | 36,633,000 | $31,784,000 | 0.37% |